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Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease with a high global prevalence.
The main scientific societies dedicated to the management of this disease have published clinical practice guidelines for quality
practice. However, at present, there are important weaknesses in COPD diagnosis criteria that often lead to underdiagnosis or
misdiagnosis.
Objective: We sought to develop a new support system for COPD diagnosis. The system was designed to overcome the
weaknesses detected in current guidelines with the goals of enabling early diagnosis, and improving the diagnostic accuracy and
quality of care provided.
Methods: We first analyzed the main clinical guidelines for COPD to detect weaknesses that exist in the current diagnostic
process, and then proposed a redesign based on a business process management (BPM) strategy for its optimization. The BPM
system acts as a backbone throughout the process of COPD diagnosis in this proposed approach. The newly developed support
system was integrated into a health information system for validation of its use in a hospital environment. The system was
qualitatively evaluated by experts (n=12) and patients (n=36).
Results: Among the 12 experts, 10 (83%) positively evaluated our system with respect to increasing the speed for making the
diagnosis, helping in interpreting results, and encouraging opportunistic diagnosis. With an overall rating of 4.29 on a 5-point
scale, 27/36 (75%) of patients considered that the system was very useful in providing a warning about possible cases of COPD.
The overall assessment of the system was 4.53 on a 5-point Likert scale with agreement to extend its use to all primary care
centers.
Conclusions: The proposed system provides a functional method to overcome the weaknesses detected in the current diagnostic
process for COPD, which can help foster early diagnosis, while improving the diagnostic accuracy and quality of care provided.
(J Med Internet Res 2020;22(3):e17161)  doi: 10.2196/17161
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Introduction
Chronic Obstructive Pulmonary Disease
Chronic diseases represent the leading cause of mortality
worldwide, and are currently responsible for almost 60% of all
deaths [1]. These diseases are of long duration and usually of
slow progression, significantly affecting quality of life. In
particular, cancer, diabetes, and heart and respiratory diseases
are chronic diseases with relatively higher prevalence, and
chronic obstructive pulmonary disease (COPD) is categorized
in the latter group.
The Global Initiative for Chronic Obstructive Lung Disease
describes COPD as “a common, preventable and treatable
disease that is characterized by persistent respiratory symptoms
and airflow limitation that is due to airway and/or alveolar
abnormalities usually caused by significant exposure to noxious
particles or gases” [2]. According to the latest Global Health
Observatory data, COPD ranked as the third leading cause of
death worldwide, responsible for approximately 5% of all deaths
globally in 2015 (3.17 million deaths) [3]. The prevalence and
burden of COPD are projected to increase over the coming
decades due to the gradual aging of the population, cumulative
smoking exposure, and an increase in underdiagnosis [4,5].
The main national and international scientific societies dedicated
to the management of COPD developed consensus regulations
and clinical practice guidelines, including recommendations for
quality clinical practice [4,6-10]. However, the processes
described in the current guidelines suffer from important
weaknesses for each of the different subprocesses, especially
in the diagnostic subprocess. Numerous studies have
demonstrated that COPD is often misdiagnosed, leading to
inappropriate treatments [11,12]. Accordingly, there has been
substantial research effort dedicated to improving diagnosis
based on the use of clinical decision support systems, mainly
involving machine-learning techniques to make an accurate
diagnosis [13-15]. However, since none of these initiatives is
based on a standardized process, they have only offered partial
solutions to resolving this problem.
Since COPD is a chronic disease, constant supervision is
required throughout the patient’s life to obtain greater control
and avoid possible exacerbations; thus, management of the
disease imposes high costs to the health care system and
population [7,16-19]. In this context, early diagnosis of COPD
is essential to prevent its progression, improve the quality of
life of patients, and reduce the economic impact borne by public
health systems.
Business Process Management
Fields such as manufacturing and business have long been
developing strategies and paradigms related to process
optimization for the continuous improvement of processes aimed
at customer satisfaction and execution of these processes,
resulting in models with demonstrated success. Business process
management (BPM) is one of the most recent process
management strategies with the greatest impact, which is
focused on the continuous improvement of business processes
using information technology as one of its fundamental
principles for process execution [20]. BPM consists of a set of
methodologies and technologies for the identification, modeling,
analysis, execution, control, and improvement of business
processes. The BPM strategy seeks to achieve flexibility and
agility in the evolution and dynamism of business processes
and their associated computer systems. Although the BPM
strategy was initially applied in the health field for improvement
of administrative tasks, in the last decade, such strategies and
associated BPM systems (BPMSs) have begun to be used for
the partial management of clinical processes [18,21-24] with
successful outcomes. A BPMS includes tools for process
modeling such as BPM notation (BPMN), which is a standard
notation based on flowcharts that facilitate process modeling.
This notation has been specifically designed to coordinate the
sequence of processes and messages that flow between the
participants for different activities [25]. BPMN provides a
common language so that all parties involved can communicate
the processes clearly, completely, and efficiently. For any
BPMS, the BPMN can be directly translated into a format that
best supports process execution.
In this study, we developed a support system for the early
diagnosis of COPD based on the BPM approach, which was
designed to foster early diagnosis, and improve diagnostic
accuracy and the quality of care provided. These objectives will
also help to indirectly achieve other secondary goals such as
shortening diagnostic times, avoiding unnecessary visits to
health care centers, creating awareness about the disease, and
helping to reduce associated costs.
We first analyzed the current diagnostic process to identify its
main weaknesses, and developed a redesign for its optimization.
We then conducted a questionnaire-based survey in a hospital
setting with experts and patients for a qualitative assessment of
the architecture of the proposed support system and the
developed prototype.
Methods
Current Chronic Obstructive Pulmonary Disease
Diagnostic Process Analysis
The consensus regulations and clinical practice guidelines of
the main national and international scientific societies include
recommendations for quality clinical practice in the management
of COPD [4,6-10]. In general, the diagnostic process for COPD
is based on 4 steps (Figure 1): evaluation (Figure 1A), diagnosis
(Figure 1B), risk stratification (Figure 1C), and classification
(Figure 1D).
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Figure 1. COPD diagnostic process in a primary care center.
The current process begins in primary care centers when the
patient is referred because of respiratory symptoms. The doctor
is responsible for carrying out an initial screening to detect key
indicators for considering a diagnosis of COPD. Clinical
suspicion is recommended for any patient older than 35-40 years
who has symptoms such as dyspnea, chronic cough, chronic
sputum production, recurrent lower respiratory tract infections,
exposure to risk factors, or a family history of COPD.
The doctor can perform a physical examination to detect, for
example, edema or anomalous values of blood pressure, or
respiratory and cardiac frequency. However, this test will rarely
have diagnostic value, since the numerous physical signs of
COPD typically do not appear until there is significant lung
function impairment. In the case of clinical suspicion, the doctor
must prepare a detailed medical history including information
such as the patient’s exposure to risk factors, medical history
of COPD or other chronic respiratory diseases, history of
exacerbations, or presence of comorbidities.
To confirm the diagnosis, a postbronchodilator forced
spirometry test must be performed. Airflow obstruction is
considered to exist if the quotient between the forced expiratory
volume in the first second (FEV1) and the forced vital capacity
(FVC) is lower than 0.7. In case of doubt, and mainly to rule
out alternative diagnoses or establish the presence of
comorbidities, the doctor may request other complementary
diagnostic tests, which generally include an X-ray, chest
tomography, blood analysis, and pulse oximetry. With all this
information, the doctor must be able to diagnose the patient a
priori. Otherwise, the patient must be referred to hospital care
to be further evaluated by a specialist [4].
The next step is to assess the severity of the disease. Since
COPD is a heterogeneous condition, no single measure can
adequately assess disease severity in an individual. In general,
the degree of affectation is estimated by taking into account the
airflow limitation (measured through FEV1), number of
exacerbations, and degree of dyspnea, which allows for
determination of severity among four stages or levels: mild,
moderate, severe, and very severe. If the patient is determined
to be at an advanced stage of the disease, they must be referred
to hospital care for treatment by a pulmonologist. Once
diagnosed, the doctor will define a treatment that allows for
reducing the symptomatology to improve the patient’s quality
of life, reduce the frequency of exacerbations, and control
disease progression.
Identification of Main Weaknesses in the Diagnostic
Process
The diagnosis of COPD in primary care centers has
inefficiencies and weaknesses that directly affect the patients’
quality of life and raise the economic cost borne by public health
systems. In general, the diagnostic process starts when the
patient suffering from respiratory problems arrives for a
consultation. However, an “opportunistic” search is more
profitable in a primary care setting [4,8]; that is, a physician
takes the opportunity to assess whether the patient is among the
at-risk population when they arrive for a consultation for other
reasons. This is partly due to the fact that a large number of
patients with COPD can remain asymptomatic until reaching
advanced stages of the disease, which increases the ratio of
undiagnosed individuals [5].
Standardization of respiratory function tests is necessary to
achieve early detection and secondary prevention of the disease,
including identification of all affected individuals and
assessment of the severity of each patient. However, there are
currently numerous nonunified clinical guidelines with
differences both in the initial screening and in the assessment
of the severity of the disease, resulting in the use of different
diagnostic criteria in different countries. Some of these
guidelines suggest that any adult with a respiratory symptom
is considered to be at risk for COPD [10,26,27], whereas others
discard individuals under 35 [7,8] or 40 years [4,6]. Other
guidelines subordinate the clinical suspicion to the condition
of smoker or ex-smoker [8,9], or to the score obtained in a
screening test [28].
Some clinical guidelines establish the stage of the disease based
solely on the FEV1, which measures airway obstruction [9,10].
Other guidelines apply multidimensional indices [6,8] that have
demonstrated proven risk predictive capacity [29,30] taking
into account FEV1 in addition to factors such as dyspnea,
number of exacerbations, body mass index, or even the
cardiopulmonary response to exercise. However, some authors
absolutely reject the use of such factors, arguing that they do
not provide better prediction outcomes than FEV1 alone, and
require more time to classify and several resources that are not
available in all primary care centers [7].
Spirometry is considered to be the most reproducible,
standardized, and objective way of measuring airflow limitation;
however, this can also be an important weak point in the
diagnostic process. In many cases, this test is not performed or
the quality of the test is very low (it is performed inefficiently)
for different reasons, including lack of an available spirometer,
the technique is not known or there is no experienced staff to
J Med Internet Res 2020 | vol. 22 | iss. 3 | e17161 | p. 3https://www.jmir.org/2020/3/e17161
(page number not for citation purposes)
De Ramón Fernández et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
perform the test, the results are not interpreted correctly,
technological errors (calibration errors), errors made by the
patient, or the results are not recorded in the medical history.
Moreover, the fixed value threshold of 0.7 suggested by the
main clinical guidelines can lead to overdiagnosis, and therefore
a variable threshold based on the age and sex of the patient has
been proposed [31,32].
Misdiagnosis of COPD also occurs due to errors made in
primary care. Some studies have shown that professionals in
primary care centers make more diagnostic errors than
specialists, mainly due to lack of awareness of the disease, which
often leads to the criteria for hospital referral to be ignored or
the associated reports not including all of the recommended
information [33].
A further challenge in COPD diagnosis is the similar
symptomatology to other diseases such as asthma, lung cancer,
acute coronary syndrome, and ischemic heart disease [34-38].
Finally, misdiagnosis can occur owing to factors related to the
characteristics of the patient. For example, women in general
and asymptomatic patients are at higher risk of underdiagnosis,
as well as overweight or obese patients. In addition, different
ethnic groups have different lung capacities that can also lead
to misdiagnosis [33].
These inefficiencies result in substantial levels of misdiagnosis,
underdiagnosis, and poor diagnostic accuracy. Some studies
have shown that primary care physicians have problems in
diagnosing up to 19.8% of patients with chronic respiratory
symptoms and that the underdiagnosis rate exceeds 70% [12,39].
Figure 2 shows a cause-effect diagram based on Ishikawa et al
[40] with a summary of the main weaknesses detected. All of
these inefficiencies consequently result in increased costs
associated with COPD diagnosis, mainly because the patients
must return for several consultations until an accurate diagnosis
is obtained, or due to overuse of hospital resources (diagnostic
tests). Therefore, an early diagnosis would help to significantly
reduce the costs associated with the treatment of a patient with
COPD.
Figure 2. Ishikawa diagram of COPD misdiagnosis.
Business Process Management Redesign Process
Based on the detected weaknesses described above, we here
propose a redesign of the COPD diagnostic process to facilitate
its comprehensive management and optimization. This redesign
is based on a BPMS that serves as a backbone throughout the
process and allows achievement of the main objectives: foster
early diagnosis, improve diagnostic accuracy, and improve the
quality of care provided. These objectives will be achieved from
process standardization, the traceability of the tasks, notification
to the patients, verification of the correct performance and
correct interpretation of the spirometry test, diagnosis
suggestion, and provision of all of the necessary information to
assist the doctor during the diagnosis. The system functionalities
are discussed below.
BPMS allows for modeling the process graphically using the
BPMN that serves as a reference for standardization of the
diagnosis, and to clearly define the tasks to be performed and
the responsibility of the actors involved (doctor, nurse, patient,
or the health information system [HIS]) in performing them
(Figure 3). The modeling of the process allows the BPMS to
ensure the traceability of all tasks and appropriate
communication in real time to the professionals involved. The
BPMS is responsible for controlling the process, guiding the
professional, and ensuring that all of the tasks assigned are
performed. Another important factor of a BPMS is the recording
of the realization time of each task. This aspect is fundamental
within a continuous improvement approach since it can help to
detect which tasks are slowing/dilating the process or consuming
more time, and the current process can be modified without the
need to reprogram the entire system.
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Figure 3. Chronic obstructive pulmonary disease diagnosis clinical process redesign using business process management notation. EPOC: excess
postexercise oxygen consumption.
The process in the diagnosis of COPD begins at a
preconsultation stage when a patient requests a medical
appointment through an HIS. This appointment does not
necessarily have to be motivated by a problem relating to COPD.
The BPMS can interact with legacy systems, in this case, a
hospital management system. If the patient requesting the
appointment meets certain indications such as being over 40
years of age, the BPMS captures this information, classifies the
patient within the population at risk, and sends a message to the
patient so that they perform an initial screening (see Figure 3).
This notification will only be sent to patients who have not
already carried out this evaluation in the last 2 years. The
screening allows for opportunistically detecting patients who
are among the population at risk of COPD and, in many cases,
in the early stages of the disease. The BPMS is responsible for
collecting and evaluating the results of the screening. If the
result is positive, both the patient and the doctor are notified of
a probable case of COPD and the clinical suspicion is recorded
in the system. In this way, the doctor knows the patient’s risk
situation before the medical appointment. To prevent the patient
from forgetting the appointment and improve the absenteeism
rates of patients in primary care consultations, which have been
estimated between 10% and 15% [38], the system sends a
notification with a reminder 24 hours in advance of the
appointment.
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The process continues in the consultation on the day of the
appointment with a more detailed evaluation of the patient by
the doctor (symptomatology, risk factors, previous
exacerbations, presence of comorbidities, family history, and
impact on quality of life), along with an update of the patient’s
medical history. If a case of COPD is suspected, the spirometry
test is performed by the nurse. First, the BPMS is responsible
for verifying if the spirometer is calibrated (usually by checking
the last calibration date), and otherwise provides information
and assistance to the professional for performing the calibration.
Before performing the test, the system reproduces an audio file
with instructions to the patient for the correct performance of
the maneuver. The results are either collected automatically by
the system or imputed manually by the professional, depending
on the level of automation and integration of the spirometer.
The test is supervised at all times by the nurse verifying its
acceptability. To do this, the nurse must correctly interpret the
spirometric diagrams shown by the spirometer. To assist the
professional in this task, a template is shown (see Figure 4) with
a normal spirometric volume flow curve and others incorrectly
performed for different reasons (eg, slow start, early termination,
glottis closure, or variable effort).
Figure 4. (a) Diagrams for normal spirometry; (b) Examples of incorrect spirometries. FEV1: forced expiratory volume (first second); FVC: forced
vital capacity.
Next, the system checks whether the test meets the
reproducibility criteria. For this step, the difference between
the two best FVC and FEV1 values of the three attempts made
must be less than or equal to 0.15 L. Otherwise, it is reported
that the test is not valid and must be repeated. If both criteria
are met, spirometry is validated and recorded, and the test result
is analyzed based on the normal lower limit calculated for each
patient according to their age, sex, and race. In this work, we
have chosen to use this metric since some studies have shown
that this approach has better diagnostic accuracy than the use
of the fixed limit of 0.7 proposed by the main clinical guidelines
[41,42]. If the spirometry result is negative, the patient is ruled
out as having COPD and other diagnoses are assessed. In the
case of a positive result, the doctor may require additional tests
(eg, chest X-ray, blood count, oximetry) to confirm the
diagnosis. With the results of the initial screening, medical
history, spirometry results, and complementary tests, the doctor
must make a differential diagnosis to rule out other respiratory
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diseases. This is a key step, since COPD may have common
symptomatology to other diseases that induce diagnostic errors.
At this point, the system provides key information on
pathologies with a similar clinical picture to help the doctor
make the differential diagnosis of COPD (see Table 1). Once
other possible diagnoses have been ruled out, the doctor makes
a diagnosis of COPD and proceeds to assess the severity of the
disease.
Table 1. Differential diagnoses for respiratory diseases.
Suggested FeaturesDiagnosis
Onset in midlife
Symptoms slowly progressive
History of tobacco smoking or exposure to other types of smoke
COPDa
Onset early in life (often in childhood)
Symptoms vary widely from day to day
Symptoms worse at night/early morning
Allergy, rhinitis, and/or eczema also present
Family history of asthma
Obesity coexistence
Asthma
Chest X-ray shows dilated heart, pulmonary edema
Pulmonary function tests indicate volume restriction, not airflow limitation
Congestive heart failure
Large volumes of purulent sputum
Commonly associated with bacterial infection
Chest radiograph/CTb scans show bronchial dilatation, bronchial wall thickening
Bronchiectasis
Onset at all ages
Chest X-ray shows lung infiltrate
Microbiological confirmation
High local prevalence of tuberculosis
Tuberculosis
Onset at younger age, nonsmokers
May have history of rheumatoid arthritis or acute fume exposure
Seen after lung or bone marrow transplantation
CT on expiration shows hypodense areas
Obliterative bronchiolitis
Predominantly seen in patients of Asian descent
Most patients are male and nonsmokers
Almost all cases involve chronic sinusitis
Chest X-ray and HRCTc show diffuse small centrilobular nodular opacities and hyperinflation
Diffuse panbrochiolitis
aCOPD: chronic obstructive pulmonary disease.
bCT: computed tomography.
cHRCT: high-resolution computed tomography.
Classification of the severity of the disease is based on the
automatic calculation of the exacerbation of the body mass
index, airflow obstruction, dyspnea, and exercise (BODEx) [43]
and/or (BODE) [44] indices together with evaluation of the
impact of the disease on the patient's quality of life. To do this,
together with the FEV1 value obtained in the spirometry, the
body mass index, degree of dyspnea, number of exacerbations,
and scoring of the 6-minute walk test (if applicable) and the
COPD assessment test [39] are recorded.
The system classifies the patient according to four levels of
severity (mild, moderate, severe, and very severe) and four
levels of impact on their quality of life (low, moderate, high,
and very high), and refers the case to a specialist if the degree
of affectation is severe or very severe, or if frequent
exacerbations are noted. In this case, the doctor must complete
the referral report proposed by the system. Otherwise, the doctor
defines the most appropriate treatment and ends the process.
Evaluation
The experimentation phase of the proposal was approached
from two different but complementary perspectives
corresponding to the two types of users involved in the system:
the health professionals who are the users and managers of the
system, and the patients who are the direct beneficiaries of the
execution of the proposed system. It is important to emphasize
that both types of users are active users; that is, they are both
involved and affected by the execution of the system. Therefore,
we consider that the opinion of both types of users is the best
result of experimentation that can be obtained, since validation
with clinical experience would correspond to a project focused
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on clinical validation and not on the tool itself as in the present
case.
To validate the achievement of the objectives proposed in the
design of the system, a Likert-type survey [45] was conducted
with 16 questions focused on the objectives associated with the
project for the health care professional, and another survey of
the same type with 6 targeted questions on the perception of
quality of care and empowerment aimed at patients. Each
question is associated with a numerical value from 1 to 5, with
1 being “completely disagree” and 5 being “totally agree.” In
addition, another open question was incorporated so that the
respondents can assess the system qualitatively. It was
emphasized to the respondents to focus on evaluating the system
comprehensively and not on its separate parts. The questions
were designed so as to cover the objectives proposed in this
work to provide a tool that can offer an idea of the degree of
achievement of the objectives. The issues raised in the
questionnaire were related to the main objectives of promoting
early diagnosis, improving diagnostic accuracy, and improving
quality of care.
Results
System Architecture and Prototype
To validate the proposed redesign for COPD diagnosis, a
technical architecture was developed that allows for the design
of realistic systems. A prototype of the architecture was
developed to demonstrate its suitability. Specific technological
tools were selected for the prototype, although these could be
replaced by similar tools provided they are in line with the
architecture. 
Since this is a distributed architecture, in which different and
geographically distributed users (patients and professionals),
apps, and software modules are identified, we adopted a
service-oriented architecture (SOA) that allows for proper
integration of these aspects. Specifically, we selected
RESTFul type services, which provide characteristics that are
fundamental to the proposal such as reusability, scalability, low
coupling, interoperability, and security [46]. 
The designed architecture (Figure 5) incorporates the following
components as key points: 
• An information system (1 in Figure 5), which includes all
of the necessary information for the proposed system. The
information system is composed of two elements, a database
server and an application server, that were run on a single
device in the prototype but could also be implemented on
different computers. 
• A database server (2 in Figure 5), in which all data
necessary for the system will be saved. In the prototype,
MariaDB is used as the database manager, which is a fork
opensource of the MySQL relational database [47]. 
• An application server that implements a Representational
State Transfer (REST) application programming interface
(API) [48] (A in Figure 5) for access to the information
system (3 in Figure 5). In the prototype, this server was
developed using NodeJS as a platform together with
the Express module for the development of HTTP services,
and the MySQL module was used for access to the
database. 
• A BPMS to execute the processes defined in the proposed
redesign (4 in Figure 5). In the prototype, Bonita Software
Community Edition (version 7.9.4; Bonitasoft, San
Francisco, CA, USA) was used that allows access through
a REST API (D in Figure 5). Toward this end, several
conductors were developed for the different tasks identified
in the process (Figure 3) that allow access to other elements
of the architecture. 
• An electronic health records system (EHRS), in which the
developed system is integrated. This is a key aspect of the
proposal since it allows validating its use in a real
environment (5 in Figure 5). For this purpose, we selected
OpenEMR [49], which is a widely used open-source EHRS.
This system uses a REST API (B in Figure 5) for access to
its information (eg, patients, appointments, treatments).
This API does not contain any notification mechanism;
thus, the BPMS is not able to know when an appointment
is requested by the patient. To solve this problem, at the
end of each day, all of the new appointments made are
consulted, those meeting the established criteria are
analyzed, and, if applicable, a notification is sent to the
patient to perform the screening. The following services
are used for this process: auth (for authorization),
appointment (for access to appointments), and patient (for
access to patient data). 
• A spirometer (6 in Figure 5) with which the doctor can
perform spirometry to the patient in consultation. This may
be connected to the system or can operate independently,
in which case the doctor must enter the data into the system
manually (G in Figure 5). An AirNext model
spirometer (NuvoAir AB, Stockholm, Sweden) was used
in the prototype.
• A mobile app for the patient to perform the screening on
COPD (7 in Figure 5 and Figure 6d). This app is operated
by an app server that collects the test results using the
defined REST API (C in Figure 5).
• The app that the patient uses to request the initial
appointment (8 in Figure 5) that is the trigger of the COPD
diagnosis process. In the prototype, the OpenEMR - Patient
Portal app was used for this purpose (Figure 6a). 
• An app to assist the doctor in the diagnostic process (9 in
Figure 5). For the prototype, an app was designed using
Bonita Software forms (Figures 6b and 6c) that use the
Bonita API (D in Figure 5). 
• The app with which the doctor manages the clinical process
(10 in Figure 5). The Web app provided by OpenEMR was
used in the prototype.
After development of the prototype, its functional validation
was conducted, including complete cycles of COPD diagnoses
from the request for an appointment by a patient to the final
diagnosis by a professional.
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Figure 5. Proposed architecture and prototype. COPD: chronic obstructive pulmonary disorder; BPM: business process management; PMS: process
management strategy.
Figure 6. Prototype screenshots. (a) Appointment management from the OpenEMR Patient Portal. (b) Test spirometry interface. (c) Severity assessment
interface. (d) Screening app.
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Evaluation Outcomes
Table 2 shows a list of the questions asked to the clinical staff,
as well as the mean and median obtained for each question from
the 5-point Likert scale.
Table 2. Questionnaire and result from the clinical perspective (N=12).
MedianMean (SD)Questions
54.56 (0.51)Q1. The system will facilitate increasing the detection of COPDa cases by opportunistic diagnosis
44.01 (0.79)Q2. The system will allow improvements in COPD diagnosis
43.24 (0.77)Q3. Thanks to the system, the patient will be aware of their pathology
33.09 (0.71)Q4. The system will help avoid diagnostic confusion
44.31 (0.49)Q5. The system will correctly assist health personnel in the diagnosis of COPD
54.47 (0.52)Q6. The use of the system will help to avoid mistakes made in primary care centers due to lack of specialized per-
sonnel
54.64 (0.49)Q7. The system will avoid unnecessary visits by patients with COPD
32.29 (1.00)Q8. The system will help to standardize a protocol for the diagnosis of the disease
54.26 (0.77)Q9. Thanks to the system, the interpretation of the spirometric test results will be improved
32.45 (0.98)Q10. The use of the system will improve the coordination, monitoring, and traceability of the diagnostic process
54.64 (0.49)Q11. The system will help speed up the diagnostic process
33.30 (0.49)Q12. The system will improve the information provided by primary care centers to hospital centers
43.36 (1.00)Q13. The system will help assess alternatives in the diagnosis
44.31 (0.49)Q14. The use of the system will reduce the number of visits due to issues associated with COPD
54.64 (0.49)Q15. The system will help improve spirometry performance
44.29 (0.65)Q16. Overall assessment of the system
aCOPD: chronic obstructive pulmonary disease.
The questionnaire was completed by 12 medical professionals,
including family doctors (n=6) who monitor patients with
COPD, emergency doctors (n=2) who care for patients when
they have exacerbations, and nursing staff (n=4) who perform
diagnostic tests. As shown in Table 2, the overall assessment
of the system was generally good, highlighting the issues from
Q7, Q11, and Q15 with mean scores above 4.5, indicating that
health personnel strongly agree that the system can avoid
unnecessary visits by patients with COPD, expedite the
diagnostic process, and help improve the performance of
spirometry. By contrast, the health personnel did not generally
agree that the system would help to standardize a protocol for
the diagnosis of the disease or that it would contribute to
improving patient adherence to treatments. In this sense, it is
important to highlight that these objectives would not be among
the main associates of the system. In qualitative assessment, all
respondents agreed on the need to use information and
communications technologies to improve the quality of care,
and this system is an example of this. Overall, 10/12 (83%) of
the experts positively evaluated our tool to help speed up the
diagnosis, help interpret the results, and also encourage
opportunistic diagnosis, recommending its use in health centers,
with an overall assessment of the system of 4.29 out of 5.
Table 3 shows the questions provided in the survey to the
patients as well as the mean and median of their answers. The
survey was completed by 36 patients with suspected COPD
between 40 and 65 years of age, including 20 (55%) men and
16 (45%) women. Although this is a small sample, it serves as
a proof of concept to present the overall perspective of patients
regarding the benefits of the system. In general, the patients had
a positive opinion about the use of the system; 27/36 (75%) of
the patients considered that the system was very useful to warn
about possible cases of COPD (Q1), highlighting their interest
in the system being extended to different health centers (Q5).
By contrast, patients did not view the system as a key factor in
improving their awareness of the disease (Q4), matching with
the opinion of the clinical staff on this aspect. The patients
provided a global rating of the system of 4.53 out of 5.
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Table 3. Questionnaire and results from the patient perspective (N=36).
MedianMean (SD)Questions
44.42 (0.50)Q1. The system can help detect the disease
44.28 (0.67)Q2. You feel more confident in the diagnosis thanks to the system
44.04 (0.74)Q3. The use of the system helps improve your quality of life as a patient
33.16 (0.63)Q4. The system helps you to be more aware of your disease
54.76 (0.42)Q5. The use of the system should be extended to all health centers
54.53 (0.50)Q6. Overall assessment of the system
Discussion
Principal Findings
COPD is a chronic respiratory disease that is associated with
high morbidity worldwide. The main scientific societies
dedicated to the care of patients with COPD have proposed
different clinical guidelines over the years to help with its
diagnosis and subsequent treatment. However, the COPD
diagnostic process continues to present important weaknesses
that cause late diagnosis or misdiagnosis. This has a direct
impact on patient quality of life and the cost borne by health
systems.
In this work, a support system for COPD diagnosis based on
the BPM paradigm was developed in order to foster early
diagnosis, and to improve diagnostic accuracy and the quality
of care provided. The BPM strategy pursues, among other
objectives, the optimization and standardization of processes,
and allows the integration of human resources and information
technology solutions through a BPMS that acts as a backbone
throughout the diagnostic process.
To instantiate the redesign model raised for the diagnosis
optimization, an architecture based on the SOA paradigm was
designed that allows integration with characteristics of low
coupling, reusability, scalability, interoperability, and security,
typical of this type of architecture. The proposed architecture
was designed to assist health care professionals during the
diagnosis of COPD through the acquisition of patient
information, storage and processing of data, and provision of
the necessary clinical information for correct interpretation of
the results.
From the definition of the architecture, a prototype was designed
for a functional validation of the system. It is important to note
that the system developed within an HIS was integrated into
the prototype, which validates that the proposal can be integrated
into a real hospital environment.
The system was also qualitatively validated by both clinical
experts and patients. Overall, 83% of the experts surveyed
positively evaluated our tool to help speed up the diagnosis,
help interpret the results, and also encourage opportunistic
diagnosis, recommending its use in health centers, with an
overall assessment of the system of 4.29 on a 5-point scale. In
addition, 75% of patients considered that the system was very
useful to warn about possible cases of COPD, especially those
who presented symptomatology compatible with the disease,
and they agreed to extend its use to all primary care centers,
with an overall assessment of the system of 4.53 on a 5-point
scale.
Limitations
This study has some limitations that must be addressed in the
next steps of development. First, the implementation of external
systems in a real hospital environment is quite restricted, which
requires bureaucratic procedures and authorizations that affect
different aspects of implementation. In addition, each hospital
has its own hospital management system, and therefore it would
be necessary to adapt our system to meet the integration
requirements in each case. Second, and as a consequence of the
first limitation, although the developed system overcomes the
current weaknesses of guidelines for COPD diagnosis, it has
not been possible to quantitatively validate how our system will
improve the current diagnosis rates.
Conclusions
This study highlights the difficulties that currently exist in the
diagnosis of COPD in primary care centers. From a functional
point of view, the proposed system can help to overcome the
weaknesses detected in the current diagnostic process through
integration of a mobile app so that patients can refer their
symptoms, a spirometer to measure the patient’s lung capacity,
and a Web app for physicians that allows them to consult all of
the information provided by both the patients and the
system. Implementation of this system is expected to help foster
the early diagnosis, and improve the diagnostic accuracy and
quality of care provided for COPD.
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